Literature DB >> 19221019

Influenza virus resistance to oseltamivir: what are the implications?

Douglas M Fleming1, Alex J Elliot, Adam Meijer, W John Paget.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19221019     DOI： 10.1093/eurpub/ckp012

Source DB:  PubMed          Journal:  Eur J Public Health        ISSN： 1101-1262            Impact factor:   3.367


× No keyword cloud information.
  3 in total

Review 1.  Oseltamivir in seasonal, avian H5N1 and pandemic 2009 A/H1N1 influenza: pharmacokinetic and pharmacodynamic characteristics.

Authors:  Nicolas Widmer; Pascal Meylan; Anton Ivanyuk; Manel Aouri; Laurent A Decosterd; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2010-11       Impact factor: 6.447

2.  Age-prioritized use of antivirals during an influenza pandemic.

Authors:  Stefano Merler; Marco Ajelli; Caterina Rizzo
Journal:  BMC Infect Dis       Date:  2009-07-28       Impact factor: 3.090

Review 3.  Combined inhalational and oral supplementation of ascorbic acid may prevent influenza pandemic emergency: a hypothesis.

Authors:  Dibyajyoti Banerjee; Deepak Kaul
Journal:  Nutrition       Date:  2010-01       Impact factor: 4.008
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.